Sun Pharma Advanced Research Company Limited (SPARC.NS) NSE

135.61

+1.6(+1.19%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap47.49B
Enterprise Value50.16B
P/E Ratio-16.46
PEG Ratio-1.56
Price/Sales Ratio73.84
Price/Book Ratio-12.75
Enterprise/Revenue80.81
Enterprise/EBITDA-20.48

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-4.48
Operating Margin-4.3

Management Effectiveness

Return On Assets-0.83
Return On Equity1.25

Income Statement

Revenue717.7M
Revenue/Share1.84
Gross Profit486.5M
EBITDA-3.23B
Net Income-3.43B
Diluted EPS-10.55

Balance Sheet

Total Cash30M
Total Cash/Share0.09
Total Debt4.17B
Total Debt/Equity-1.21
Current Ratio0.03
Book Value Per Share-10.63

Price History

52-Week Change-32.63
52-Week High208.3
52-Week Low109.3
Moving Average 50 Days136.22
Moving Average 200 Days146.77

Statistics

Average Volume4.64M
Shares Outstanding324.52M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor127:125
Last Split DateAugust 23, 2012